NewswireToday - /newswire/ -
Basel, Switzerland, 2007/06/26 - Swiss-based firm Genedata has established a subsidiary in Japan. The new offices in Tokyo pave the way for a full professional services base in Japan to provide local support for life sciences research with a focus on pharmaceutical research - Genedata.jp.
Swiss-based computational biology firm Genedata has established a subsidiary, Genedata KK, in Japan. The new offices in Tokyo’s Shinagawa district pave the way for a full professional services base in Japan, from which to provide local support for life sciences research with a focus on pharmaceutical research.
Japan is becoming an important global player in pharmaceutical research and development. Over the past few years, major Japanese pharmaceutical companies have expanded their research activities in the Asia region and beyond.
This has created demand for enterprise-level computational solutions for life sciences and drug discovery research. Genedata KK aims to satisfy this demand and to enable expansion of the company’s existing collaborations in Japan.
Each of Genedata’s international subsidiaries delivers computational support according to a proven collaborative framework. Genedata’s professional services points in the US, Europe and now Asia, ensure the smooth operation and evolution of its products and services.
Genedata has already attracted experienced people to the new subsidiary. The growing team, headed by Dr. Frank Staubli, brings broad knowledge and experience of the bioinformatics business in Japan. This has helped Genedata to maneuver quickly into focused business areas, such as screening analysis and biomarker discovery as applied to toxicogenomics.
With more than five years experience providing support for drug discovery research on a global scale, Genedata has tailored its products and services for use in enterprise-wide and multi-site contexts. “We aim to help global research enterprises to bring together the best aspects of their research cultures,” explained Genedata CEO Dr. Othmar Pfannes.
Genedata specializes in discovery informatics for biotech, pharmaceuticals and the life sciences. The Company offers expertise in research informatics combined with open and scalable computational solutions. Our solutions include Genedata Phylosopher® for integrating, structuring, and analyzing research data. Genedata Screener® for high throughput screening analysis. And Genedata Expressionist® for omics data integration, processing and analysis. Founded in 1997 as a privately held spin off from Novartis, Genedata is headquartered in Basel, Switzerland and has branches in Tokyo (Japan), Munich (Germany), Boston (USA) and San Francisco (USA). The Company is also represented in Taiwan and Singapore.
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.